$ATVK
Ameritek Ventures, Inc. Stock $atvk

$atvk Overview Financials Valuation SEC Filings Company Website

2023 Q4 Form 10-K Financial Statement

#000137647424000150 Filed on April 01, 2024

Income Statement

Concept	2023 Q4	2023	2022
Revenue	$246.5K	$949.4K	$1.076M
YoY Change		-11.79%
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin	$140.0K	$740.3K	$1.214M
YoY Change		-39.0%
% of Gross Profit
Research & Development		$516.5K	$902.1K
YoY Change		-42.75%
% of Gross Profit
Depreciation & Amortization	$11.90K	$84.49K	$204.9K
YoY Change		-58.77%
% of Gross Profit
Operating Expenses	$150.1K	$822.9K	$1.418M
YoY Change		-41.99%
Operating Profit		$126.5K	-$342.2K
YoY Change		-136.98%
Interest Expense	-$72.74K	-$185.5K	$509.1K
YoY Change		-136.43%
% of Operating Profit		-146.55%
Other Income/Expense, Net		-$185.5K	$509.1K
YoY Change		-136.43%
Pretax Income	$23.69K	-$58.91K	$166.9K
YoY Change		-135.3%
Income Tax
% Of Pretax Income
Net Earnings	$23.69K	-$58.91K	$166.9K
YoY Change		-135.3%
Net Earnings / Revenue	9.61%	-6.2%	15.51%
Basic Earnings Per Share		$0.00	$0.00
Diluted Earnings Per Share	$0.00	$0.00	$0.00
COMMON SHARES
Basic Shares Outstanding	514.2M shares	554.2M shares	514.2M shares
Diluted Shares Outstanding		554.2M shares	514.2M shares

Balance Sheet

Concept	2023 Q4	2023	2022
SHORT-TERM ASSETS
Cash & Short-Term Investments	$5.620K	$5.620K	$750.00
YoY Change		649.33%
Cash & Equivalents	$5.618K
Short-Term Investments
Other Short-Term Assets	$1.520K	$1.520K	$1.520K
YoY Change		0.0%
Inventory
Prepaid Expenses	$1.519K
Receivables	$132.4K	$132.4K	$374.0K
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$139.5K	$139.5K	$376.3K
YoY Change	-62.92%	-62.92%
LONG-TERM ASSETS
Property, Plant & Equipment	$0.00	$0.00	$0.00
YoY Change
Goodwill	$2.185M
YoY Change
Intangibles
YoY Change
Long-Term Investments	$661.9K	$661.9K	$661.9K
YoY Change		0.0%
Other Assets	$35.11K	$35.11K	$0.00
YoY Change	-98.74%
Total Long-Term Assets	$3.656M	$3.656M	$3.703M
YoY Change	-1.28%	-1.28%
TOTAL ASSETS
Total Short-Term Assets	$139.5K	$139.5K	$376.3K
Total Long-Term Assets	$3.656M	$3.656M	$3.703M
Total Assets	$3.795M	$3.795M	$4.080M
YoY Change	-6.97%	-6.97%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$987.1K	$987.1K	$1.191M
YoY Change	-17.12%	-17.12%
Accrued Expenses	$547.2K	$547.2K	$426.8K
YoY Change	28.2%	28.2%
Deferred Revenue
YoY Change
Short-Term Debt	$21.00K	$21.00K	$21.00K
YoY Change	0.0%	0.0%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$1.706M	$1.706M	$2.025M
YoY Change	-15.75%	-15.75%
LONG-TERM LIABILITIES
Long-Term Debt	$1.933M	$1.933M	$1.756M
YoY Change		10.11%
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities	$1.933M	$1.933M	$1.756M
YoY Change		10.11%
TOTAL LIABILITIES
Total Short-Term Liabilities	$1.706M	$1.706M	$2.025M
Total Long-Term Liabilities	$1.933M	$1.933M	$1.756M
Total Liabilities	$3.640M	$3.640M	$3.781M
YoY Change	-3.74%	-3.74%
SHAREHOLDERS EQUITY
Retained Earnings	-$2.379M
YoY Change	2.54%
Common Stock	$554.2K
YoY Change	7.78%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$155.6K	$155.6K	$298.4K
YoY Change
Total Liabilities & Shareholders Equity	$3.795M	$3.795M	$4.080M
YoY Change	-6.97%	-6.97%

Cashflow Statement

Concept	2023 Q4	2023	2022
OPERATING ACTIVITIES
Net Income	$23.69K	-$58.91K	$166.9K
YoY Change		-135.3%
Depreciation, Depletion And Amortization	$11.90K	$84.49K	$204.9K
YoY Change		-58.77%
Cash From Operating Activities	-$196.3K	-$23.01K	$278.1K
YoY Change		-108.27%
INVESTING ACTIVITIES
Capital Expenditures	$0.00	$0.00	$36.07K
YoY Change		-100.0%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities	$0.00	$0.00	-$36.07K
YoY Change		-100.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	194.4K	27.88K	-270.0K
YoY Change		-110.33%
NET CHANGE
Cash From Operating Activities	-196.3K	-23.01K	278.1K
Cash From Investing Activities	0.000	0.000	-36.07K
Cash From Financing Activities	194.4K	27.88K	-270.0K
Net Change In Cash	-1.880K	4.870K	-27.93K
YoY Change		-117.44%
FREE CASH FLOW
Cash From Operating Activities	-$196.3K	-$23.01K	$278.1K
Capital Expenditures	$0.00	$0.00	$36.07K
Free Cash Flow	-$196.3K	-$23.01K	$242.1K
YoY Change		-109.51%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2023	dei	Amendment Flag AmendmentFlag	false
CY2023	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2023
CY2023	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2023	dei	Document Type DocumentType	10-K
CY2023	dei	Document Annual Report DocumentAnnualReport	true
CY2023	dei	Document Period End Date DocumentPeriodEndDate	2023-12-31
CY2023	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2023	dei	Document Transition Report DocumentTransitionReport	false
CY2023	dei	Entity File Number EntityFileNumber	000-54739
CY2023	dei	Entity Registrant Name EntityRegistrantName	Ameritek Ventures, Inc.
CY2023	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	NV
CY2023	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	87-2380777
CY2023	dei	Entity Address Address Line1 EntityAddressAddressLine1	325 N Milwaukee Ave. Suite G1
CY2023	dei	Entity Address City Or Town EntityAddressCityOrTown	Wheeling
CY2023	dei	Entity Address State Or Province EntityAddressStateOrProvince	IL
CY2023	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	60090
CY2023	dei	Entity Address Address Description EntityAddressAddressDescription	Address of principal executive offices
CY2023	dei	City Area Code CityAreaCode	312
CY2023	dei	Local Phone Number LocalPhoneNumber	239-3574
CY2023	dei	Phone Fax Number Description PhoneFaxNumberDescription	Issuer’s telephone number
CY2023	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	No
CY2023	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2023	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2023	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2023	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2023	dei	Entity Small Business EntitySmallBusiness	true
CY2023	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2023	dei	Icfr Auditor Attestation Flag IcfrAuditorAttestationFlag	false
CY2023	dei	Document Fin Stmt Error Correction Flag DocumentFinStmtErrorCorrectionFlag	false
CY2023	dei	Document Fin Stmt Restatement Recovery Analysis Flag DocumentFinStmtRestatementRecoveryAnalysisFlag	false
CY2023	dei	Entity Shell Company EntityShellCompany	false
CY2023Q2	dei	Entity Public Float EntityPublicFloat	0	usd
CY2023Q4	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	554226791	shares
CY2023	dei	Entity Listing Par Value Per Share EntityListingParValuePerShare	0.001
CY2023	dei	Auditor Name AuditorName	Bansal & Co. LLP
CY2023	dei	Auditor Firm AuditorFirmId	2807
CY2023	dei	Auditor Location AuditorLocation	New Delhi, India
CY2023Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	5618	usd
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	751	usd
CY2023Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	132380	usd
CY2022Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	374003	usd
CY2023Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	1519	usd
CY2022Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	1519	usd
CY2023Q4	us-gaap	Assets Current AssetsCurrent	139517	usd
CY2022Q4	us-gaap	Assets Current AssetsCurrent	376273	usd
CY2023Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	0	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	0	usd
CY2023Q4	us-gaap	Short Term Lease Commitment Amount ShortTermLeaseCommitmentAmount	35112	usd
CY2022Q4	us-gaap	Short Term Lease Commitment Amount ShortTermLeaseCommitmentAmount	0	usd
CY2023Q4	us-gaap	Marketable Securities Noncurrent MarketableSecuritiesNoncurrent	661886	usd
CY2022Q4	us-gaap	Marketable Securities Noncurrent MarketableSecuritiesNoncurrent	661886	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	250000	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	250000	usd
CY2023Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	524117	usd
CY2022Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	0	usd
CY2023Q4	us-gaap	Goodwill Goodwill	2184715	usd
CY2022Q4	us-gaap	Goodwill Goodwill	2791472	usd
CY2023Q4	us-gaap	Assets Noncurrent AssetsNoncurrent	3655830	usd
CY2022Q4	us-gaap	Assets Noncurrent AssetsNoncurrent	3703358	usd
CY2023Q4	us-gaap	Assets Assets	3795347	usd
CY2022Q4	us-gaap	Assets Assets	4079631	usd
CY2023Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	987071	usd
CY2022Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	1191025	usd
CY2023Q4	us-gaap	Interest And Dividends Payable Current InterestAndDividendsPayableCurrent	547204	usd
CY2022Q4	us-gaap	Interest And Dividends Payable Current InterestAndDividendsPayableCurrent	426842	usd
CY2023Q4	us-gaap	Deferred Revenue DeferredRevenue	151005	usd
CY2022Q4	us-gaap	Deferred Revenue DeferredRevenue	386496	usd
CY2023Q4	us-gaap	Short Term Borrowings ShortTermBorrowings	21000	usd
CY2022Q4	us-gaap	Short Term Borrowings ShortTermBorrowings	21000	usd
CY2023Q4	us-gaap	Liabilities Current LiabilitiesCurrent	1706280	usd
CY2022Q4	us-gaap	Liabilities Current LiabilitiesCurrent	2025363	usd
CY2023Q4	us-gaap	Long Term Notes Payable LongTermNotesPayable	1933448	usd
CY2022Q4	us-gaap	Long Term Notes Payable LongTermNotesPayable	1755899	usd
CY2023Q4	us-gaap	Liabilities Liabilities	3639728	usd
CY2022Q4	us-gaap	Liabilities Liabilities	3781262	usd
CY2023Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2022Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2023Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	950000000	shares
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	950000000	shares
CY2023Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	554226791	shares
CY2023Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	554226791	shares
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	514226791	shares
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	514226791	shares
CY2023Q4	us-gaap	Common Stock Value CommonStockValue	554227	usd
CY2022Q4	us-gaap	Common Stock Value CommonStockValue	514227	usd
CY2023Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	885038	usd
CY2022Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	1239878	usd
CY2023Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-2379259	usd
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-2320349	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	155619	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	298369	usd
CY2023Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	3795347	usd
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	4079631	usd
CY2023	us-gaap	Revenues Revenues	949438	usd
CY2022	us-gaap	Revenues Revenues	1076286	usd
CY2023	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	516474	usd
CY2022	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	902061	usd
CY2023	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	223505	usd
CY2022	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	299634	usd
CY2023	us-gaap	Labor And Related Expense LaborAndRelatedExpense	277	usd
CY2022	us-gaap	Labor And Related Expense LaborAndRelatedExpense	11854	usd
CY2023	us-gaap	Depreciation And Amortization DepreciationAndAmortization	82640	usd
CY2022	us-gaap	Depreciation And Amortization DepreciationAndAmortization	204941	usd
CY2023	us-gaap	Operating Expenses OperatingExpenses	822896	usd
CY2022	us-gaap	Operating Expenses OperatingExpenses	1418490	usd
CY2023	us-gaap	Operating Income Loss OperatingIncomeLoss	126542	usd
CY2022	us-gaap	Operating Income Loss OperatingIncomeLoss	-342204	usd
CY2023	us-gaap	Other Nonoperating Income OtherNonoperatingIncome	0	usd
CY2022	us-gaap	Other Nonoperating Income OtherNonoperatingIncome	661886	usd
CY2023	us-gaap	Interest Expense InterestExpense	185452	usd
CY2022	us-gaap	Interest Expense InterestExpense	152803	usd
CY2023	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-185452	usd
CY2022	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	509083	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	-58910	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	166879	usd
CY2023	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0
CY2022	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0
CY2023	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0
CY2022	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0
CY2023	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	554226791	shares
CY2022	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	514226791	shares
CY2023	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	554226791	shares
CY2022	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	514226791	shares
CY2021Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	131490	usd
CY2022	us-gaap	Net Income Loss Including Portion Attributable To Nonredeemable Noncontrolling Interest NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest	166879	usd
CY2022Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	298369	usd
CY2023	us-gaap	Stock Issued During Period Value Other StockIssuedDuringPeriodValueOther	36960	usd
CY2023	us-gaap	Repayments Of Debt RepaymentsOfDebt	164000	usd
CY2023	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities Net Of Adjustments StockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesNetOfAdjustments	43200	usd
CY2023	us-gaap	Net Income Loss Including Portion Attributable To Nonredeemable Noncontrolling Interest NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest	-58910	usd
CY2023Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	155619	usd
CY2023	us-gaap	Profit Loss ProfitLoss	-58910	usd
CY2022	us-gaap	Profit Loss ProfitLoss	166879	usd
CY2023	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	82640	usd
CY2022	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	204941	usd
CY2023	fil	Sale Of Patent SaleOfPatent	0	usd
CY2022	fil	Sale Of Patent SaleOfPatent	661886	usd
CY2023	us-gaap	Adjustment For Amortization AdjustmentForAmortization	1848	usd
CY2022	us-gaap	Adjustment For Amortization AdjustmentForAmortization	0	usd
CY2023	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-241623	usd
CY2022	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	119898	usd
CY2023	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	0	usd
CY2022	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	-22778	usd
CY2023	us-gaap	Increase Decrease In Accounts Payable Trade IncreaseDecreaseInAccountsPayableTrade	-203954	usd
CY2022	us-gaap	Increase Decrease In Accounts Payable Trade IncreaseDecreaseInAccountsPayableTrade	406959	usd
CY2023	us-gaap	Increase Decrease In Interest Payable Net IncreaseDecreaseInInterestPayableNet	149235	usd
CY2022	us-gaap	Increase Decrease In Interest Payable Net IncreaseDecreaseInInterestPayableNet	117218	usd
CY2023	us-gaap	Increase Decrease In Deferred Liabilities IncreaseDecreaseInDeferredLiabilities	-235491	usd
CY2022	us-gaap	Increase Decrease In Deferred Liabilities IncreaseDecreaseInDeferredLiabilities	141124	usd
CY2023	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-23009	usd
CY2022	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	278115	usd
CY2023	fil	Product Development Expenditures ProductDevelopmentExpenditures	0	usd
CY2022	fil	Product Development Expenditures ProductDevelopmentExpenditures	-36071	usd
CY2023	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	0	usd
CY2022	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-3607	usd
CY2023	us-gaap	Proceeds From Issuance Of Long Term Debt ProceedsFromIssuanceOfLongTermDebt	243613	usd
CY2022	us-gaap	Proceeds From Issuance Of Long Term Debt ProceedsFromIssuanceOfLongTermDebt	37000	usd
CY2023	us-gaap	Repayments Of Other Debt RepaymentsOfOtherDebt	215737	usd
CY2022	us-gaap	Repayments Of Other Debt RepaymentsOfOtherDebt	306979	usd
CY2023	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	27876	usd
CY2022	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-269979	usd
CY2023	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	4867	usd
CY2022	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-27935	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	751	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	28686	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	5618	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	751	usd
CY2023	us-gaap	Interest Paid InterestPaid	152715	usd
CY2022	us-gaap	Interest Paid InterestPaid	152803	usd
CY2023	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	0	usd
CY2022	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	444	usd
CY2023	us-gaap	Other Significant Noncash Transaction Value Of Consideration Received1 OtherSignificantNoncashTransactionValueOfConsiderationReceived1	0	usd
CY2022	us-gaap	Other Significant Noncash Transaction Value Of Consideration Received1 OtherSignificantNoncashTransactionValueOfConsiderationReceived1	661886	usd
CY2023	us-gaap	Nature Of Operations NatureOfOperations	<p style="font:9pt Times New Roman;margin-top:0pt;margin-bottom:10pt;margin-left:18pt"><kbd style="position:absolute;font:9pt Times New Roman;margin-left:-18pt"><b>1.</b></kbd><b>GENERAL ORGANIZATION AND BUSINESS</b> </p> <p style="font:9pt Times New Roman;margin:0;text-align:justify">The Company was organized on December 27, 2010, under the laws of the State of Nevada, as ATVROCKN. On June 20, 2017, the Company changed its corporate name to Ameritek Ventures, Inc (“Ameritek Ventures” or “Ameritek” or the “Company”).</p> <p style="font:9pt Times New Roman;margin:0;text-align:justify"> </p> <p style="font:9pt Times New Roman;margin:0;text-align:justify">Ameritek is a group of companies that provides various world-class software and hardware products and services beneficial to businesses, organizations, and governments. We have an established presence in the warehouse solutions market. With Interactive Systems, Inc. we provide software inventory management and with interlinkONE, Inc. we provide SaaS cloud-based solutions for warehouse and inventory fulfillment. We manufacture and innovate advanced technological developments in the medical industry, such as the DittoMask high-filtration mask. We also develop blockchain technology software programs under WebBeeO and CordTell companies. Furthermore, Ameritek Ventures explores augmented reality technology with Augmum, Inc. Meanwhile, our vertical landing aircraft service from AeroPass, Inc. takes ZenaDrone technology to a higher level with members-only passenger first-class transport across cities. Ecker Capital, LLC is our merger and acquisition division. ESM Software, Inc. is a software technology provider specializing in developing business strategy management solutions. The Company also recently created a new business, Equock, Inc., with which Ameritek will develop an electric bicycle with a focus on the growing online delivery industry.</p>
CY2023	dei	Entity Incorporation Date Of Incorporation EntityIncorporationDateOfIncorporation	2010-12-27
CY2023	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	NV
CY2023	us-gaap	Use Of Estimates UseOfEstimates	<p style="font:9pt Times New Roman;margin:0;text-align:justify"><b>Use of Estimates</b></p> <p style="font:9pt Times New Roman;margin:0;text-align:justify">The preparation of financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amount of revenues and expenses during the reporting period. Actual results could differ from those estimates.</p>
CY2023	us-gaap	Advertising Expense AdvertisingExpense	7212	usd
CY2023Q4	us-gaap	Furniture And Fixtures Gross FurnitureAndFixturesGross	7694	usd
CY2022Q4	us-gaap	Furniture And Fixtures Gross FurnitureAndFixturesGross	7694	usd
CY2023Q4	us-gaap	Machinery And Equipment Gross MachineryAndEquipmentGross	28568	usd
CY2022Q4	us-gaap	Machinery And Equipment Gross MachineryAndEquipmentGross	28568	usd
CY2023Q4	us-gaap	Capitalized Computer Software Net CapitalizedComputerSoftwareNet	4200	usd
CY2022Q4	us-gaap	Capitalized Computer Software Net CapitalizedComputerSoftwareNet	4200	usd
CY2023Q4	us-gaap	Capital Leased Assets Gross CapitalLeasedAssetsGross	2783	usd
CY2022Q4	us-gaap	Capital Leased Assets Gross CapitalLeasedAssetsGross	2783	usd
CY2023Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	43245	usd
CY2022Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	43245	usd
CY2023Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	43245	usd
CY2022Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	43245	usd
CY2023Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	0	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	0	usd
CY2022Q4	fil	Product Development Costs ProductDevelopmentCosts	3150159	usd
CY2023	us-gaap	Goodwill Transfers GoodwillTransfers	2184715	usd
CY2023Q4	fil	Product Development Costs ProductDevelopmentCosts	965444	usd
CY2022Q4	fil	Product Development Cost Book Value ProductDevelopmentCostBookValue	2791472	usd
CY2022Q4	fil	Product Development Total Amortizatiion ProductDevelopmentTotalAmortizatiion	358687	usd
CY2023	fil	Product Development Cost Amortization Transfer To Goodwill ProductDevelopmentCostAmortizationTransferToGoodwill	2184716	usd
CY2023	fil	Product Development Amortization ProductDevelopmentAmortization	82637	usd
CY2023Q4	fil	Product Development Total Amortizatiion ProductDevelopmentTotalAmortizatiion	441324	usd
CY2023Q4	fil	Product Development Net Book Value ProductDevelopmentNetBookValue	524119	usd
CY2023	us-gaap	Debt Instrument Issuance Date1 DebtInstrumentIssuanceDate1	2021-05-13
CY2023	us-gaap	Debt Instrument Issuer DebtInstrumentIssuer	Ameritek
CY2023Q4	us-gaap	Debt Instrument Face Amount DebtInstrumentFaceAmount	185000	usd
CY2023	us-gaap	Debt Instrument Description DebtInstrumentDescription	non-convertible promissory note
CY2023Q4	us-gaap	Debt Instrument Interest Rate Stated Percentage DebtInstrumentInterestRateStatedPercentage	0.15	pure
CY2023Q4	us-gaap	Long Term Debt LongTermDebt	24596	usd
CY2023Q4	us-gaap	Interest Payable Current InterestPayableCurrent	3596	usd
CY2022Q4	us-gaap	Long Term Debt LongTermDebt	23167	usd
CY2022Q4	us-gaap	Interest Payable Current InterestPayableCurrent	2167	usd
CY2023Q4	fil	Promissory Notes Current PromissoryNotesCurrent	0	usd
CY2022Q4	fil	Promissory Notes Current PromissoryNotesCurrent	0	usd
CY2023Q4	fil	Promissory Notes Non Current PromissoryNotesNonCurrent	1933448	usd
CY2022Q4	fil	Promissory Notes Non Current PromissoryNotesNonCurrent	1755899	usd
CY2023Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	547204	usd
CY2022Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	424675	usd
CY2023Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	950000000	shares
CY2023Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2023Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	950000000	shares
CY2023Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	554226791	shares
CY2023Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	554226791	shares
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	950000000	shares
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	514226791	shares
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	514226791	shares
CY2023	us-gaap	Loss Contingency Lawsuit Filing Date LossContingencyLawsuitFilingDate	May 6, 2019
CY2023	us-gaap	Loss Contingency Actions Taken By Plaintiff LossContingencyActionsTakenByPlaintiff	Meridian Pacific Holdings, LLC filed a lawsuit against certain directors, officers, affiliates, and the Company
CY2023	us-gaap	Loss Contingency Name Of Plaintiff LossContingencyNameOfPlaintiff	Meridian Pacific Holdings, LLC
CY2023	us-gaap	Loss Contingency Allegations LossContingencyAllegations	breach of contract and fraud
CY2023	us-gaap	Loss Contingency Domicile Of Litigation LossContingencyDomicileOfLitigation	Superior Court of the State of California, County of Los Angeles
CY2023	us-gaap	Gain Contingency Description GainContingencyDescription	On March 6, 2021, the Company filed a lawsuit in the Clark County, Nevada, court against Clinton L. Stokes, III, the former owner of the Company, to settle the matter of shares ownership
CY2022	us-gaap	Other Significant Noncash Transaction Value Of Consideration Received1 OtherSignificantNoncashTransactionValueOfConsiderationReceived1	661886	usd
CY2022	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	661887	usd
CY2022	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	661887	usd
CY2022Q4	us-gaap	Operating Loss Carryforwards OperatingLossCarryforwards	0	usd
CY2023	us-gaap	Income Taxes Paid IncomeTaxesPaid	0	usd
CY2022	us-gaap	Income Taxes Paid IncomeTaxesPaid	0	usd

Files In Submission

Name	View Source	Status
0001376474-24-000150-index-headers.html	Edgar Link	pending
0001376474-24-000150-index.html	Edgar Link	pending
0001376474-24-000150.txt	Edgar Link	pending
0001376474-24-000150-xbrl.zip	Edgar Link	pending
atvk-20231231.htm	Edgar Link	pending
atvk-20231231.xsd	Edgar Link	pending
av10k_1.jpg	Edgar Link	pending
av10k_2.jpg	Edgar Link	pending
av_ex31z1.htm	Edgar Link	pending
av_ex31z2.htm	Edgar Link	pending
av_ex32z1.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
atvk-20231231_cal.xml	Edgar Link	unprocessable
atvk-20231231_def.xml	Edgar Link	unprocessable
atvk-20231231_pre.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable
atvk-20231231_htm.xml	Edgar Link	completed
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
atvk-20231231_lab.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$ATVK
Ameritek Ventures, Inc. Stock $atvk

2023 Q4 Form 10-K Financial Statement

#000137647424000150 Filed on April 01, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$ATVK Ameritek Ventures, Inc. Stock $atvk

2023 Q4 Form 10-K Financial Statement

#000137647424000150 Filed on April 01, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$ATVK
Ameritek Ventures, Inc. Stock $atvk